Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile

  • Gregory L. Peterfreund,

    Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  • Lee E. Vandivier,

    Affiliation Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  • Rohini Sinha,

    Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  • Andre J. Marozsan,

    Current address: Alexion Pharmaceuticals, Cheshire, Connecticut, United States of America

    Affiliation Progenics Pharmaceuticals, Tarrytown, New York, United States of America

  • William C. Olson,

    Affiliation Progenics Pharmaceuticals, Tarrytown, New York, United States of America

  • Jun Zhu,

    Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  • Frederic D. Bushman

    bushman@mail.med.upenn.edu

    Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile

  • Gregory L. Peterfreund, 
  • Lee E. Vandivier, 
  • Rohini Sinha, 
  • Andre J. Marozsan, 
  • William C. Olson, 
  • Jun Zhu, 
  • Frederic D. Bushman
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.